These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Retrospective study on the characteristics and treatment of late-onset vitiligo. Kong YL; Ching VHL; Chuah SY; Thng TG Indian J Dermatol Venereol Leprol; 2017; 83(5):625. PubMed ID: 28656913 [TBL] [Abstract][Full Text] [Related]
3. Classification of segmental vitiligo on the trunk. van Geel N; Bosma S; Boone B; Speeckaert R Br J Dermatol; 2014 Feb; 170(2):322-7. PubMed ID: 24117138 [TBL] [Abstract][Full Text] [Related]
4. Six-year follow-up of vitiligo patients successfully treated with autologous non-cultured melanocyte-keratinocyte transplantation. Altalhab S; AlJasser MI; Mulekar SV; Al Issa A; Mulekar S; Diaz J; Diallo A; Ezzedine K J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1172-1176. PubMed ID: 30793805 [TBL] [Abstract][Full Text] [Related]
5. Different phenotypes of segmental vitiligo based on a clinical observational study. van Geel N; De Lille S; Vandenhaute S; Gauthier Y; Mollet I; Brochez L; Lambert J J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):673-8. PubMed ID: 20840343 [TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation. Mulekar SV Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183 [TBL] [Abstract][Full Text] [Related]
7. Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo. Ezzedine K; Diallo A; Léauté-Labrèze C; Séneschal J; Prey S; Ballanger F; Alghamdi K; Cario-André M; Jouary T; Gauthier Y; Taieb A Br J Dermatol; 2012 Mar; 166(3):539-44. PubMed ID: 22032627 [TBL] [Abstract][Full Text] [Related]
8. Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity. Fongers A; Wolkerstorfer A; Nieuweboer-Krobotova L; Krawczyk P; Tóth GG; van der Veen JP Br J Dermatol; 2009 Nov; 161(5):1105-11. PubMed ID: 19673878 [TBL] [Abstract][Full Text] [Related]
9. A descriptive study to characterize segmental vitiligo. Khaitan BK; Kathuria S; Ramam M Indian J Dermatol Venereol Leprol; 2012; 78(6):715-21. PubMed ID: 23075640 [TBL] [Abstract][Full Text] [Related]
10. CLINICAL EPIDEMIOLOGICAL PROFILE OF VITILIGO. Kiprono S; Chaula B East Afr Med J; 2012 Aug; 89(8):278-81. PubMed ID: 26852459 [TBL] [Abstract][Full Text] [Related]
11. Long-term results of split-skin grafting in combination with excimer laser for stable vitiligo. Al-Mutairi N; Manchanda Y; Al-Doukhi A; Al-Haddad A Dermatol Surg; 2010 Apr; 36(4):499-505. PubMed ID: 20180833 [TBL] [Abstract][Full Text] [Related]
12. Mixed vitiligo of Blaschko lines: a newly discovered presentation of vitiligo responsive to combination treatment. Kovacevic M; Stanimirovic A; Vucic M; Goren A; Situm M; Lukinovic Skudar V; Lotti T Dermatol Ther; 2016 Jul; 29(4):240-3. PubMed ID: 26970077 [TBL] [Abstract][Full Text] [Related]
13. Keratinocytes in the depigmented epidermis of vitiligo are more vulnerable to trauma (suction) than keratinocytes in the normally pigmented epidermis, resulting in their apoptosis. Lee AY; Youm YH; Kim NH; Yang H; Choi WI Br J Dermatol; 2004 Nov; 151(5):995-1003. PubMed ID: 15541077 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with 308-nm excimer laser, topical tacrolimus, and short-term systemic corticosteroids for segmental vitiligo: A retrospective study of 159 patients. Bae JM; Yoo HJ; Kim H; Lee JH; Kim GM J Am Acad Dermatol; 2015 Jul; 73(1):76-82. PubMed ID: 25956660 [TBL] [Abstract][Full Text] [Related]
15. Childhood vitiligo in China: clinical profiles and immunological findings in 620 cases. Lin X; Tang LY; Fu WW; Kang KF Am J Clin Dermatol; 2011 Aug; 12(4):277-81. PubMed ID: 21668034 [TBL] [Abstract][Full Text] [Related]
16. Clinical course of 44 cases of localized type vitiligo. Zaima H; Koga M J Dermatol; 2002 Jan; 29(1):15-9. PubMed ID: 11837568 [TBL] [Abstract][Full Text] [Related]
17. Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study. Mazereeuw-Hautier J; Bezio S; Mahe E; Bodemer C; Eschard C; Viseux V; Labreze C; Plantin P; Barbarot S; Vabres P; Martin L; Paul C; Lacour JP; J Am Acad Dermatol; 2010 Jun; 62(6):945-9. PubMed ID: 20466172 [TBL] [Abstract][Full Text] [Related]
18. Clinical profiles of vitiligo in China: an analysis of 3742 patients. Liu JB; Li M; Yang S; Gui JP; Wang HY; Du WH; Zhao XY; Ren YQ; Zhu YG; Zhang XJ Clin Exp Dermatol; 2005 Jul; 30(4):327-31. PubMed ID: 15953059 [TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Kemp EH; Emhemad S; Akhtar S; Watson PF; Gawkrodger DJ; Weetman AP Exp Dermatol; 2011 Jan; 20(1):35-40. PubMed ID: 21158937 [TBL] [Abstract][Full Text] [Related]
20. The distribution pattern of segmental vitiligo: clues for somatic mosaicism. van Geel N; Speeckaert R; Melsens E; Toelle SP; Speeckaert M; De Schepper S; Lambert J; Brochez L Br J Dermatol; 2013 Jan; 168(1):56-64. PubMed ID: 22913564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]